Clinical signs of androgen excess as risk factors for coronary artery disease.

[1]  G. Schneider,et al.  Androgen-estrogen metabolism in women with upper body versus lower body obesity. , 1990, The Journal of clinical endocrinology and metabolism.

[2]  R. Wild,et al.  The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome. , 1988, American journal of obstetrics and gynecology.

[3]  A. Dunaif,et al.  The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. , 1988, The Journal of clinical endocrinology and metabolism.

[4]  P. Coulson,et al.  Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. , 1985, The Journal of clinical endocrinology and metabolism.

[5]  L. Mattsson,et al.  Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease. , 1984, Fertility and sterility.

[6]  K. Gould,et al.  Cardiovascular imaging: coronary artery stenosis. , 1984, Hospital practice.

[7]  M. Kirschner.  Hirsutism and virilism in women. , 1984, Special topics in endocrinology and metabolism.

[8]  R. Hoffmann,et al.  Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. , 1983, The Journal of clinical endocrinology and metabolism.

[9]  A. Kissebah,et al.  Relation of Body Fat Distribution to Metabolic Complications of Obesity , 1982 .

[10]  E. Bolson,et al.  Quantitative Coronary Angiography: Measurement of the "Critical" Stenosis in Patients with Unstable Angina and Single-Vessel Disease Without Collaterals , 1979, Circulation.

[11]  R. Horton,et al.  3α-Androstanediol Kinetics in Man , 1974 .

[12]  K. Lipscomb,et al.  Effects of coronary stenoses on coronary flow reserve and resistance. , 1974, The American journal of cardiology.

[13]  Albert R. Behnke,et al.  Evaluation and regulation of body build and composition , 1974 .

[14]  G W Hamilton,et al.  Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. , 1974, The American journal of cardiology.

[15]  P. Mauvais-Jarvis,et al.  Simultaneous determination of urinary androstanediol and testosterone as an evaluation of human androgenicity. , 1973, The Journal of clinical endocrinology and metabolism.

[16]  C. Bardin,et al.  The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5-alpha-androstanediols. , 1971, The Journal of clinical investigation.

[17]  J. Goldzieher,et al.  The polycystic ovary. I. Clinical and histologic features. , 1962, The Journal of clinical endocrinology and metabolism.